(Q51191319)

1 April 2018

title

Is there a reduced sensitivity of dihydroartemisinin against praziquantel-resistant Schistosoma japonicum? (English)

1 reference

1 April 2018

main subject

Schistosoma japonicum

object named as

Schistosoma japonicum

1 reference

7

You-Sheng Liang

1 reference

1 April 2018

Jian-Rong Dai

6

object named as

Jian-Rong Dai

1 reference

1 April 2018

author name string

Wei Wang

1

1 reference

1 April 2018

Hong-Jun Li

2

1 reference

1 April 2018

Guo-Li Qu

3

1 reference

1 April 2018

Yun-Tian Xing

4

1 reference

1 April 2018

Zhen-Kun Yang

5

1 reference

1 April 2018

publication date

22 October 2013

1 reference

1 April 2018

published in

Parasitology Research

1 reference

1 April 2018

volume

113

1 reference

1 April 2018

issue

1

1 reference

1 April 2018

page(s)

223-228

1 reference

1 April 2018

https://scigraph.springernature.com/pub.10.1007/s00436-013-3647-1

exact match

0 references

cites work

Chemotherapy of schistosomiasis: present and future

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years' experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Drug resistance in schistosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Schistosomiasis: challenges for control, treatment and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Chlorpromazine, other amphiphilic cationic drugs and praziquantel: effects on carbohydrate metabolism of Schistosoma mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Chemotherapeutic approaches to schistosomes: current knowledge and outlook

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

The future of artemisinins: natural, synthetic or recombinant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Effect of praziquantel prolonged administration on granuloma formation around Schistosoma japonicum eggs in lung of sensitized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

The biochemical basis of anthelmintic action and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Case report: Schistosoma mansoni infection: failure of standard treatment with praziquantel in a returned traveller

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Effects of artemether, artesunate and dihydroartemisinin administered orally at multiple doses or combination in treatment of mice infected with Schistosoma japonicum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Dihydroartemisinin-praziquantel combinations and multiple doses of dihydroartemisinin in the treatment of Schistosoma japonicum in experimentally infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

In-vivo activity of dihydroartemisinin against Schistosoma japonicum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Effect of the in vivo activity of dihydroartemisinin against Schistosoma mansoni infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Artemisinin: mechanisms of action, resistance and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Schistosomiasis--a century searching for chemotherapeutic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Human schistosomiasis resistance to praziquantel in China: should we be worried?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

The effects of dihydroartemisinin on Giardia lamblia morphology and cell cycle in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

The efficacy of praziquantel against Schistosoma mansoni infection in Ndombo, northern Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Is there reduced susceptibility to praziquantel in Schistosoma japonicum? Evidence from China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Susceptibility or resistance of praziquantel in human schistosomiasis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Chemistry of artemisinin: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

New insight into praziquantel against various developmental stages of schistosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Application of praziquantel in schistosomiasis japonica control strategies in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Research and development of antischistosomal drugs in the People's Republic of China a 60-year review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Efficacy of praziquantel against Schistosoma japonicum: field evaluation in an area with repeated chemotherapy compared with a newly identified endemic focus in Hunan, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Effects of the praziquantel-based control of schistosomiasis japonica in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

A diagnostic challenge for Schistosomiasis japonica in China: consequences on praziquantel-based morbidity control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Synthesis and properties of Praziquantel, a novel broad spectrum anthelmintic with excellent activity against Schistosomes and Cestodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

Quantification of praziquantel-induced damage on the surface of adultSchistosoma mansoni worms: estimation of esterase and alkaline phosphatase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3647-1

A case of refractory schistosomiasis

21 January 2018

1 reference

12 December 2020

Antimalarials in the treatment of schistosomiasis.

1 reference

12 December 2020

Activity of dihydroartemisinin against Leishmania donovani both in vitro and vivo

1 reference

12 December 2020

Laboratory induced resistance to praziquantel in experimental schistosomiasis

1 reference

12 December 2020

Schistosomiasis control in China: the impact of a 10-year World Bank Loan Project (1992-2001).

1 reference

12 December 2020

Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni.

1 reference

12 December 2020

Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni.

1 reference

12 December 2020

Praziquantel, a new broad-spectrum antischistosomal agent

1 reference

12 December 2020

1 reference

12 December 2020

Time course of the effect of praziquantel on Schistosoma mansoni attachment in vitro: comparison with its effects on worm length and motility

1 reference

12 December 2020

[Studies on resistance of Schistosoma to praziquantel XIV experimental comparison of susceptibility to praziquantel between PZQ-resistant isolates and PZQ-susceptible isolates of Schistosoma japonicum in stages of adult worms, miracidia and cercaria

1 reference

12 December 2020

In vitro study of the anti-pneumocystis carinii effect of arteminsin derivatives

1 reference

12 December 2020

[Advances in research of dihydroartemisinin against parasitic diseases]

1 reference

12 December 2020

Effects of artesunate, dihydroartemisinin, and an artesunate-dihydroartemisinin combination against Toxoplasma gondii

1 reference

12 December 2020

[Studies on resistance of Schistosoma to praziquantel XIII resistance of Schistosoma japonicum to praziquantel is experimentally induced in laboratory]

1 reference

12 December 2020

Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel.

1 reference

12 December 2020

The anthelmintic action of praziquantel

1 reference

12 December 2020

Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.

1 reference

12 December 2020

[Effect of dihydroartemisinin on the ultrastructure of Trichomonas vaginalis trophozoites in vitro]

1 reference

12 December 2020

Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa

1 reference

12 December 2020

Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection

1 reference

12 December 2020

Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.

1 reference

12 December 2020

In vivo activity of dihydroartemisinin against Schistosoma mansoni schistosomula in mice.

1 reference

12 December 2020

10.1007/S00436-013-3647-1

Identifiers

DOI

1 reference

1 April 2018

1 reference

1 April 2018